Monthly Publications
In Depth
Subscribe Now
In Depth
coverage of timely
Life Science
Compliance issues
Subscribe Now
Browsing Category
Congress
McCaskill Files Amendment to Eliminate Marketing Tax Deduction
Senator Claire McCaskill of Missouri recently filed an amendment to the tax bill to eliminate the deduction for pharmaceutical…
Insight into 21st Century Cures Implementation
According to a proposal of how 21st Century Cure funds will be used (subject to the congressional appropriations process), FDA…
Senators Blumenthal and Grassley Ask CMS to Continue Funding Open Payments
In a letter to Acting Secretary of the U.S. Department of Health and Human Services (HHS) Eric D. Hargan, United States Senators…
Senate HELP Committee Holds Hearing on Opioid Response
The Senate Committee on Health, Education Labor and Pensions (HELP) convened a hearing in early October to examine the federal…
United States Senate Focuses on Opioids
Senate Finance Committee Chairman Orrin Hatch, along with 10 of his Republican Committee colleagues, recently called on the…
House Passes Medicare Part B Improvement Bill
Earlier this year the U.S. House of Representatives passed a bipartisan bill, the Medicare Part B Improvement Act of 2017. The…
Senate Passes CHRONIC Care Act
On September 26, the Senate passed the CHRONIC Care Act is also known as the “Creating High-Quality Results and Outcomes Necessary…
HELP Committee Holds Hearing on Individual Health Insurance Market
The Senate Health, Education, Labor and Pensions (HELP) Committee recently held the first hearing of several about ways to…
After a Quiet Summer, Congress Starts Probe into MS Drugs
Congress has recently taken a few months off from constantly barraging the pharmaceutical industry with daily probes and negative…
A Murky Future for Off-label Promotion: Off-Label Bills Garner Minimal…
Further muddying the off-label waters is the fact that Congress has introduced several bills, attempting to legislate off-label…